News | June 15, 2015

New Study Validates Framework to Increase Accurate Interpretation of Echo Images

Machine learning algorithms could help novice users differentiate between hypertrophic cardiomyopathy and normally enlarged hearts

echocardiography, ASE, hypertrophic cardiomyopathy, HCM, interpretation, Narula

June 15, 2015 - A research team from New York has announced advances in automated echocardiography decision systems that could help clinicians more accurately assess complex heart disease. The team developed a system that takes a large amount of information from ultrasound images, learns about the structure and function of the heart, and automatically differentiates enlarged hearts seen in patients with hypertrophic cardiomyopathy (HCM) from a normal variation of enlarged hearts seen in athletes. The two conditions are often difficult to distinguish from each other, and misdiagnoses might have major implications, since undiagnosed HCM is one of the most common causes of sudden cardiac death in athletes, while thickening seen in athlete's heart is benign and does not generally lead to dysfunction.

"I am confident that the use of machine learning algorithms will help create a real-time clinical guidance system for interpreting echocardiographic images and this will be crucial for standardization of interpretation for novice readers and new users of cardiac ultrasound," noted primary investigator Sukrit Narula, medical student at Icahn School of Medicine at Mount Sinai. "I am fortunate to be part of Dr. Sengupta's team and their efforts in this project, especially senior investigators like Dr. Dudley, Dr. Khader and Dr. Omar who have helped bring the first steps of this effort to fruition."

Researchers on the studyAutomated Morphological and Functional Phenotyping of Human Heart with Feature Tracking of 2D Echocardiographic Images Using Machine Learning Algorithms, included Sukrit Narula, Shameer Khader, Ph.D., Sharath Vallabhajosyula, Alaa M. Omar, Joel T. Dudley, M.D., and Partho P. Sengupta, M.D., from the Icahn School of Medicine at Mount Sinai in New York, NY.

A poster based on the results of the study will be displayed in the Poster and Exhibit Hall from Saturday, June 13 through Monday, June 15 at the American Society of Echocardiography (ASE) 26th Annual Scientific Sessions at the Hynes Convention Center in Boston.

For more information: www.asescientificsessions.org

Related Content

ASNC Announces Multisocietal Cardiac Amyloidosis Imaging Consensus
News | Cardiac Imaging | September 09, 2019
September 9, 2019 — The American Society of Nuclear Cardiology (ASNC) published a new expert consensus document along
Medical Imaging Rates Continue to Rise Despite Push to Reduce Their Use
News | Radiology Imaging | September 03, 2019
Despite a broad campaign among physician groups to reduce the amount of medical imaging, use rates of various scans...
Philips Debuts Cardiac Ultrasound and Enterprise Informatics Offerings at ESC 2019
News | Cardiac Imaging | August 30, 2019
Philips will showcase its latest cardiac care innovations at the European Society of Cardiology (ESC) Congress 2019,...
CIRS Launches Ultrasound Quality Assurance Software
Technology | Quality Assurance (QA) | August 30, 2019
August 30, 2019 — The CIRS Ultrasound...
Terason Partners With DiA Imaging Analysis for Point-of-care Cardiac Ultrasound AI
News | Cardiovascular Ultrasound | August 26, 2019
Ultrasound imaging company Terason has partnered with DiA Imaging Analysis, provider of artificial intelligence (AI)-...
Exo Imaging Raises $35 Million for Developmental Ultrasound Platform
News | Ultrasound Imaging | August 23, 2019
Exo Imaging Inc. announced a $35 million Series B financing round for its high-performance ultrasound platform based on...
Improved Imaging Technique Could Increase Chances of Prostate Cancer Survival
News | Prostate Cancer | August 20, 2019
According to the American Cancer Society, approximately one in nine men will be diagnosed with prostate cancer in their...
Profound Medical Receives U.S. FDA 510(k) Clearance for Tulsa-Pro
Technology | Interventional Radiology | August 16, 2019
Profound Medical Corp. announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to...
Contrast Use in First Transthoracic Echocardiogram for Heart Failure Reduces Repeat Testing
News | Cardiovascular Ultrasound | August 07, 2019
Heart failure is the fourth most common cause for all admission to U.S. hospitals, and it is the most common reason for...